Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

23 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Brain and Central Nervous System Tumors NCT00053963 Treatment - ADVL0212: Reporting Period Worksheet (Leukemia) - 2172521v3.0 - Reporting Period Worksheet (Leukemia ADVL0212)

- 12/03/2015 - 1 Formulário, 7 Grupos de itens, 66 Elementos de dados, 1 Idioma
Grupos de itens: Header, Patient characteristics, Treatment, Concomitant Medication, New Cancer, Follow-Up, Adverse event
ADVL0212: Reporting Period Worksheet (Leukemia) FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia NCT00053963 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C0F387DC-C9D3-5664-E034-0003BA12F5E7

Eligibility NCT00915252 Acute Myeloid Leukemia - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 24 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00915252

Eligibility DRKS00000733 NCT00867672 Acute Myeloid Leukemia - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 19 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00867672

AML- Register_Therapy form_SAL_University hospital dresden

- 11/02/2016 - 1 Formulário, 7 Grupos de itens, 37 Elementos de dados, 1 Idioma
Grupos de itens: Patient information, Cancer remission, Chemotherapy, Medication, Transplantation, Toxicity grade III-IV, Therapy outcome
Items used as routine documentation for the SAL (Studienallianz Leukämie) study centre of university hospital dresden. ODM derived from original form "AML-Register Therapiebogen-D", converted to ODM format.

ADVL0212: On Study Worksheet (Leukemia) NCT00053963

- 05/07/2015 - 1 Formulário, 6 Grupos de itens, 45 Elementos de dados, 1 Idioma
Grupos de itens: Patient demographics, Bone Marrow, Hemogram, Chemistries, Comments, CCRR MODULE
ADVL0212: On Study Worksheet (Leukemia) NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C10238B2-42BD-142E-E034-0003BA12F5E7

Eligibility NCT00560794 Acute Lymphoblastic Leukemia - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 24 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00560794

ADVL0212: Eligibility Worksheet (Leukemia) NCT00053963

- 16/06/2015 - 1 Formulário, 5 Grupos de itens, 33 Elementos de dados, 1 Idioma
Grupos de itens: Header, Eligibility Assessment, Comments, Treatment Assignment, CCRR MODULE
ADVL0212: Eligibility Worksheet (Leukemia) NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C0F2D219-E599-53B9-E034-0003BA12F5E7

Eligibility NCT00684619 T-ALL, T-NHL (Lymphoblastic) - Eligibility

- 09/12/2013 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00684619

E2902 On-Study Form - Form 2050 NCT00093470

- 20/09/2021 - 1 Formulário, 9 Grupos de itens, 42 Elementos de dados, 1 Idioma
Grupos de itens: Header, Evaluation of Disease/Cancer, Current Remission, Current CR Confirmation, Bone Marrow Biopsy/Aspirate, At Any Time, Current Performance Status, Baseline Abnormalities, Comments
E2902 On-Study Form - Form 2050 NCT00093470 Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DBF6D3B9-09FD-06C3-E034-0003BA12F5E7

Eligibility Stem Cell Transplantation NCT00822770

- 15/09/2021 - 1 Formulário, 2 Grupos de itens, 17 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin; ODM derived from: https://clinicaltrials.gov/show/NCT00822770

CALGB: 10603 Follow-Up Form DRKS00003845 NCT00651261 - CALGB: 10603 Follow-Up Form NCT00651261

- 08/06/2015 - 1 Formulário, 10 Grupos de itens, 51 Elementos de dados, 1 Idioma
Grupos de itens: Header, Patient demographics, Treatment Phase Information, Vital Status, Disease Follow-Up Status, Notice of Progression, RECOVERY, Transplant Treatment Plan, Notice of New Primary Cancer, Footer Module
CALGB: 10603 Follow-Up Form NCT00651261 Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=43C5D677-EB7A-6D45-E044-0003BA3F9857

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial